Brain blood vessels are smarter than we thought -- and that opens new doors for treating brain disease
The blood-brain barrier keeps harmful substances out of the brain, but exactly how it works has largely remained a mystery. A detailed inventory of proteins on the surface of brain blood vessels reveals an unexpectedly rich molecular layer -- with direct implications for the treatment of brain disease.
The blood-brain barrier is one of the most talked-about structures in medicine. It shields the brain from toxins and microorganisms, but it is also the single biggest obstacle to delivering drugs to the brain: more than ninety percent of all potentially effective neurological drugs simply cannot get through. Researchers have now published a detailed proteome in Science -- a complete map of the proteins found on the luminal surface of brain blood vessels. That is the inner lining of the vessel wall, the interface between the blood and brain tissue.
What they found surprised the team: hundreds of proteins that had never before been associated with the blood-brain barrier, including several that appear to actively regulate how permeable the barrier is. This is not a passive wall -- it is a dynamic system that continuously processes signals and decides what gets through and what does not.
The key to drug delivery
For the pharmaceutical industry, this is a potentially significant discovery. Getting drugs across the blood-brain barrier is one of the most stubborn problems in developing treatments for Alzheimer's, Parkinson's, brain tumors, and stroke. The new protein map identifies transport molecules that could be used as a kind of 'Trojan horse': attaching drugs to molecules that are already being ferried across the barrier.
Some of the newly identified proteins also appear to be involved in regulating the barrier itself, making it more or less permeable depending on signals from the brain or the blood. That suggests the barrier does not just protect -- it actively communicates with the rest of the body. This is something that has been attracting growing attention in the field of neuroimmunology in recent years.
What this means for aging
When it comes to aging, another aspect stands out: the integrity of the blood-brain barrier declines as you get older. In elderly people and in patients with neurodegenerative diseases, the barrier becomes leakier, contributing to the chronic inflammation that accelerates brain damage. If the newly discovered proteins really do regulate that integrity, they could offer starting points for therapies that keep the barrier stronger later in life.
The study does not deliver a treatment. But for the first time it gives researchers a detailed molecular handbook for a structure that is crucial to a healthy brain -- and whose deterioration may be one of the earliest signs of cognitive decline.